As shown in Table 3, sepsis patients with a history of severe COVID-19 exhibited significantly higher IL-1β, IL-6, and IL-17 levels compared to those in the non-severe COVID-19 H group (P = .002, P <.001, and P <.001, respectively). This evidence concerns the gene IL17A and COVID-19.